Succinonitrile (SN) is investigated as an electrolyte additive for copper corrosion inhibition to provide overdischarge (OD) protection to lithium ion batteries (LIBs). The anodic Cu corrosion, occurring above 3.5 V (vs Li/Li(+)) in conventional LIB electrolytes, is suppressed until a voltage of 4.5 V is reached in the presence of SN. The corrosion inhibition by SN is ascribed to the formation of an SN-induced passive layer, which spontaneously develops on the copper surface during the first anodic scan. The passive layer is composed mainly of Cu(SN)2PF6 units, which is evidenced by Raman spectroscopy and electrochemical quartz crystal microbalance measurements. The effects of the SN additive on OD protection are confirmed by using 750 mAh pouch-type full cells of LiCoO2 and graphite with lithium metal as a reference electrode. Addition of SN completely prevents corrosion of the copper current collector in the full cell configuration, thereby tuning the LIB chemistry to be inherently immune to the OD abuses.
Astrocytes perform multiple essential functions in the developing and mature brain, including regulation of synapse formation, control of neurotransmitter release and uptake, and maintenance of extracellular ion balance. As a result, astrocytes have been implicated in the progression of neurodegenerative disorders such as Alzheimer’s disease, Huntington’s disease, and Parkinson’s disease. Despite these critical functions, the study of human astrocytes can be difficult because standard differentiation protocols are time-consuming and technically challenging, but a differentiation protocol recently developed in our laboratory enables the efficient derivation of astrocytes from human embryonic stem cells. We used this protocol along with microarrays, luciferase, EMSA and ChIP assays to explore the genes involved in astrocyte differentiation. We demonstrate that paired-like homeodomain transcription factor 1 (PITX1) is critical for astrocyte differentiation. PITX1 overexpression induced early differentiation of astrocytes and its knockdown blocked astrocyte differentiation. PITX1 overexpression also increased and PITX1 knockdown decreased sex-determining region Y box 9 (SOX9), a known initiator of gliogenesis, expression during early astrocyte differentiation. Moreover, we determined that PITX1 activates the SOX9 promoter through a unique binding motif. Taken together, these findings indicate that PITX1 drives astrocyte differentiation by sustaining activation of the SOX9 promoter.
-In order to investigate the preliminary repeat oral dose toxicity and to determine the highest dosage for further 4-week repeated dose toxicity test, Low Molecular Weight Fucoidan (LMF) has been showed various pharmacological effects, was orally administered to female and male rats, once a day for 14 days at dose levels of 2,000, 1,000, 500 and 0 (vehicle control) mg/kg (body weights) in a volume of 10 ml/kg. The mortality and changes on the body weights, clinical signs, hematology, serum biochemistry and gross observations were monitored with organ weight and histopathology of principle organs. As the results of 14-day repeated oral treatment of LMF, no LMF treatment related mortalities were detected up to 2,000 mg/kg in both male and female rats, respectively. In addition, no noticeable changes on the body weight and clinical signs were detected except for significant decreases on the body weights and gains restricted to male 2,000 mg/kg treated groups as compared with male vehicle control. No meaningful changes on the organ weights, hematological, serum biochemistrical, gross and histopathological findings were observed. Therefore the highest dosage in the 4-week repeated dose toxicity test is suggested as 2,000 mg/kg in both female and male rats, respectively.
Presently, because making process of train service plan consist of various constraint condition, for example structure of track, structure of track in station, train maintenance time and others for considering to be necessary of train management, it has been had extremely complex structure problems. For these reasons, it has big problems to compare analysis for various train service time-table. A study suggest methodology to choice service the most effective schedule and plan of train put before comparative analysis on making train diamond picture's expected effect of established possible various train time-table in making process of train service schedule for improving effectiveness and organization of train service schedule establishment. A study uses Line-Blocking theory for analyzing train service time-table and analyze example for regional train Sadang to Ansan section in 4line.
Janus kinase 2 (JAK2), a non-receptor tyrosine kinase, is a critical component of cytokine and growth factor signaling pathways regulating hematopoietic cell proliferation. JAK2 mutations are associated with multiple myeloproliferative neoplasms. Although physiological and pathological functions of JAK2 in hematopoietic tissues are well-known, such functions of JAK2 in the nervous system are not well studied yet. The present study demonstrated that JAK2 could negatively regulate neuronal differentiation of mouse embryonic stem cells (ESCs). Depletion of JAK2 stimulated neuronal differentiation of mouse ESCs and activated glycogen synthase kinase 3ꞵ, Fyn, and cyclin-dependent kinase 5. Knockdown of JAK2 resulted in accumulation of GTPbound Rac1, a Rho GTPase implicated in the regulation of cytoskeletal dynamics. These findings suggest that JAK2 might negatively regulate neuronal differentiation by suppressing the GSK-3β/ Fyn/CDK5 signaling pathway responsible for morphological maturation. [
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.